The market for biosimilar medicines represents a segment of significant growth within the prescription pharmaceutical arena that is associated with unparalleled development, market access and commercialisation challenges.

In this dynamic environment, we are uniquely positioned to provide clients with expert advice on development, registration and commercial strategies, for both generic and innovator companies. We provide strategic market access and technical consulting services in this field and offer detailed training courses on biosimilar product development and commercialisation.